Dexus's development at Quarry at Greystanes has a strong brand attraction and has created an industry clustering, securing a diverse group of high calibre tenants to anchor the estate.

Dexus has successfully developed and secured precommitments for 89% of the total 190,000 square metre masterplanned industrial estate, developing major metropolitan distribution centres for UPS, Roche Diagnostics and Symbion Healthcare.

Dexus remains on track to complete the staged development by the third quarter of 2015, with strong enquiry for the balance.